Earnings Feed
Start Free
DURECT CORP·4

Oct 18, 8:42 PM ET

YUM SU IL 4

4 · DURECT CORP · Filed Oct 18, 2012

Insider Transaction Report

Form 4
Period: 2012-10-17
DURECT CORPDRRX
YUM SU IL
Exec. VP Pharm./R&D
Transactions
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2012-10-17−28,004→ 126,840 total
    Exercise: $0.78From: 2012-02-03Exp: 2022-02-03→ Common Stock (28,004 underlying)
  • Exercise/Conversion

    Common Stock

    2012-10-17$0.78/sh+14,374$11,212→ 14,374 total
  • Exercise/Conversion

    Common Stock

    2012-10-17$0.78/sh+31,076$24,239→ 73,454 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2012-10-17−14,374→ 154,844 total
    Exercise: $0.78From: 2012-05-03Exp: 2022-02-03→ Common Stock (14,374 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2012-10-17−31,076→ 95,764 total
    Exercise: $0.78From: 2012-05-03Exp: 2022-02-03→ Common Stock (31,076 underlying)
  • Exercise/Conversion

    Common Stock

    2012-10-17$0.78/sh+28,004$21,843→ 42,378 total
Holdings

  • Common Stock

    (indirect: By Trust)
    41,816
Footnotes (3)
  • [F1]The option vested in two equal installments on May 3, 2012 and August 3, 2012.
  • [F2]Fully vested.
  • [F3]The option vested in two equal installments on May 3, 2012 and August 3, 2012.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT